<DOC>
	<DOCNO>NCT01292291</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , magnetic resonance imaging ( MRI ) , may help find prostate cancer learn extent disease . PURPOSE : This clinical trial study safety MRI see well work diagnose prostate cancer .</brief_summary>
	<brief_title>MRI Diagnosing Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine ability multiparametric magnetic resonance imaging ( MP-MRI ) identify men safely avoid unnecessary biopsy . - To assess ability MP-MRI-based diagnostic pathway improve rate detection clinically significant cancer compare transrectal ultrasound ( TRUS ) biopsy . - To estimate cost-effectiveness MP-MRI base diagnostic pathway . OUTLINE : This multicenter study . Patients undergo multiparametric magnetic resonance imaging ( MRI ) ( T2-weighted imaging , diffusion-weighted MRI , dynamic contrast-enhanced MRI ) follow template prostate mapping transrectal ultrasound biopsy . Some patient may undergo blood , urine , tissue sample collection periodically biomarker study . Samples bank future research analysis . Patients complete quality-of-life questionnaire ( EQ-5D ) baseline , , completion study . An economic analysis perform cost-effectiveness . After completion study intervention , patient follow periodically .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Men risk prostate cancer advise prostate biopsy Suspected stage ≤ T2 rectal examination ( organ confine ) Serum PSA ≤ 15 ng/mL within past 3 month PATIENT CHARACTERISTICS : Fit general/spinal anesthesia Fit undergo protocol procedure include transrectal ultrasound No evidence urinary tract infection history acute prostatitis within past 3 month No contraindication MRI ( e.g. , claustrophobia , pacemaker , estimate GFR ≤ 50 ) No medical condition precluding procedure describe protocol PRIOR CONCURRENT THERAPY : No prior prostate biopsy , prostate surgery , treatment prostate cancer ( intervention benign prostatic hyperplasia/bladder outflow obstruction acceptable ) No prior hip replacement surgery</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
</DOC>